SEED Therapeutics Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader - Check the Link for More@seedtx  @BeyondSpringInc  #FDA  #Cancer  #CancerResearch  #SolidTumors  #RareDiseases  #OrphanDrugs
#FDA #Cancer #CancerResearch #SolidTumors #RareDiseases #OrphanDrugs